|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 39/39591 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/2818 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/94 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 3496753 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17838513.4 |
| Europos patento paraiškos padavimo data | 2017-07-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-06-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-11-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2017/093141 |
| Data | 2017-07-17 |
| (87) | Numeris | WO 2018/028383 |
| Data | 2018-02-15 |
| (30) | Numeris | Data | Šalis |
| PCT/CN2016/094094 | 2016-08-09 | WO |
| (72) |
CAO, Wei , CN
LI, Junfeng , CN
LIU, Xiaolin , CN
|
| (73) |
Innovent Biologics (Suzhou) Co., Ltd. ,
168 Dongping Street
Suzhou Industrial Park, Suzhou, Jiangsu 215123,
CN
|
| (54) | PD-1 ANTIBODY FORMULATION |
| PD-1 ANTIBODY FORMULATION |